What C46 covers · when clinicians use it
ICD-10 code C46 identifies Kaposi's sarcoma in the U.S. ICD-10-CM clinical and billing record set. It sits within the Neoplasms chapter (C00–D49), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply C46 when an encounter's findings match the Kaposi's sarcoma description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify C46 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for C46 and is a coding reference, not clinical, diagnostic, or billing advice.
C46 refers to Kaposi's sarcoma, a group of rare but serious malignant tumors affecting mesothelial cells, nerves, connective tissue, or serous membranes. These cancers often require complex diagnostic workups and specialized treatments. Accurate ICD10 coding ensures proper documentation, care coordination, and cancer registry reporting.
Symptoms
- Swelling or mass – Typically painless at early stages
- Localized pain – In affected nerves, tissue, or organ areas
- Shortness of breath – Common in pleural mesothelioma
- Skin lesions – Purple or brown patches in Kaposi’s sarcoma
- Abdominal discomfort – Seen in retroperitoneal tumors
- Neurologic symptoms – Tingling, numbness, or weakness if nerves are involved
- Weight loss and fatigue – General systemic cancer signs
Diagnosis
Diagnosis of Kaposi's sarcoma includes imaging studies (CT, MRI), biopsy, immunohistochemistry, and sometimes genetic or viral testing (e.g., HHV-8 in Kaposi's sarcoma). Multidisciplinary evaluation is often needed to determine tumor type, origin, and stage, which guides the treatment plan.
ICD10 Code Usage
ICD10 code C46 is used for recording rare soft tissue and nerve-related cancers in electronic health records, insurance systems, cancer registries, and clinical trials. Accurate usage enables detailed disease tracking and supports reimbursement for specialized therapies.
Related Codes
- C45 – Mesothelioma
- C47 – Malignant neoplasm of peripheral nerves and autonomic nervous system
- C48 – Malignant neoplasm of retroperitoneum and peritoneum
- C49 – Malignant neoplasm of other connective and soft tissue
FAQs
Q1: What is ICD10 code C46?
A: It classifies Kaposi's sarcoma, a cancer of soft tissue, nerves, or mesothelium, for documentation and billing purposes.
Q2: What causes these cancers?
A: Risk factors include asbestos exposure (mesothelioma), viral infections (Kaposi’s sarcoma), radiation, and genetic syndromes.
Q3: Are they curable?
A: Some are treatable or curable if detected early, but others may require palliative care or long-term management.
Q4: What treatments are used?
A: Surgery, radiation, chemotherapy, immunotherapy, or targeted drugs depending on cancer type and stage.
Q5: Are these cancers common?
A: No, they are relatively rare and often seen in specific patient populations or as secondary cancers.
Conclusion
ICD10 code C46 is vital for identifying and managing Kaposi's sarcoma. It facilitates treatment planning, improves clinical communication, and supports global cancer surveillance. Proper use ensures accurate billing, patient care, and research into rare malignancies.